{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:47:21Z","timestamp":1750308441631},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/hco.0b013e32834fdc98","type":"journal-article","created":{"date-parts":[[2012,1,10]],"date-time":"2012-01-10T08:56:21Z","timestamp":1326185781000},"page":"161-168","source":"Crossref","is-referenced-by-count":8,"title":["Recent advances in the management of chronic heart failure"],"prefix":"10.1097","volume":"27","author":[{"given":"Haissam","family":"Haddad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Mielniczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross A.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210204","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.cjca.2011.02.010","article-title":"New and emerging drugs and device therapies for chronic heart failure in patients with systolic ventricular dysfunction.","volume":"27","author":"Rouleau","year":"2011","journal-title":"Can J Cardiol"},{"key":"R2-16-20210204","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0828-282X(06)70237-9","article-title":"Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.","volume":"22","author":"Arnold","year":"2006","journal-title":"Can J Cardiol"},{"key":"R3-16-20210204","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/eurheartj\/ehq337","article-title":"Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association.","volume":"31","author":"Dickstein","year":"2010","journal-title":"Eur Heart J"},{"key":"R4-16-20210204","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Resynchronization-Defibrillation for Ambulatory Heart Failure Trial Investigators. Cardiac-resynchronization therapy for mild to moderate heart failure.","volume":"363","author":"Tang","year":"2010","journal-title":"N Engl J Med"},{"key":"R5-16-20210204","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure.","volume":"352","author":"Cleland","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-16-20210204","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-16-20210204","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-16-20210204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"EMPHASIS-HF Study Group. Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"R9-16-20210204","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(08)61171-X","article-title":"Ferrari R on behalf of the BEAUTIFUL investigators. Heart rate as a prognostic risk factor in patients with coronary artery disease and left ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomized controlled trial.","volume":"372","author":"Fox","year":"2008","journal-title":"Lancet"},{"key":"R10-16-20210204","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.103.10.1428","article-title":", on behalf of the CIBIS II Investigators. Heart rate and cardiac rhythm relationships with bisoprolol. Benefit in chronic heart failure in CIBIS II Trial.","volume":"103","author":"Lechat","year":"2001","journal-title":"Circulation"},{"key":"R11-16-20210204","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(10)61198-1","article-title":"Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study.","volume":"376","author":"Swedberg","year":"2010","journal-title":"Lancet"},{"key":"R12-16-20210204","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/eurheartj\/ehr343","article-title":"Heart rate reduction with ivabradine and health related quality of life in patients with chronic heart failure: results from the SHIFT study.","volume":"32","author":"Ekman","year":"2011","journal-title":"Eur Heart J"},{"key":"R13-16-20210204","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(11)61229-4","article-title":"Telemedicine and remote management of patients with heart failure.","volume":"378","author":"Anker","year":"2011","journal-title":"Lancet"},{"key":"R14-16-20210204","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1056\/NEJMoa1010029","article-title":"Telemonitoring in patients with heart failure.","volume":"363","author":"Chaudhry","year":"2010","journal-title":"N Engl J Med"},{"key":"R15-16-20210204","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/eurjhf\/hfr039","article-title":"Which components of heart failure programmes are effective A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review.","volume":"13","author":"Inglis","year":"2011","journal-title":"Eur J Heart Fail"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e32834fdc98","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:53:17Z","timestamp":1620953597000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201203000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e32834fdc98","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}